Literature DB >> 20403111

Response of chronic and aggressive periodontitis to treatment.

David E Deas, Brian L Mealey.   

Abstract

Patients with aggressive periodontitis can be both rewarding and frustrating to treat in clinical practice. Interindividual variation in response to therapy can be widespread, and we do not clearly understand the reasons for this variable response. It is possible that new research into the resolution of inflammation may reveal basic differences between patients with chronic periodontitis and those with aggressive disease. In addition, future research involving modulation of host inflammatory responses may clarify the reasons for the differences in clinical outcomes between patients. We think it likely that this research could result in further alterations to the classification of periodontal diseases, as with more knowledge of the mechanisms of disease it is possible that patients currently classified as having aggressive periodontitis may be found not to represent a single diagnostic entity. Better understanding of the true nature of patients currently identified as having aggressive periodontitis may therefore lead to more effective treatment approaches.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20403111     DOI: 10.1111/j.1600-0757.2009.00334.x

Source DB:  PubMed          Journal:  Periodontol 2000        ISSN: 0906-6713            Impact factor:   7.589


  27 in total

Review 1.  Antimicrobial photodynamic therapy in the treatment of aggressive periodontitis: a systematic review and meta-analysis.

Authors:  Emmanuel Souza; Ana Cláudia Medeiros; Bruno César Gurgel; Carlos Sarmento
Journal:  Lasers Med Sci       Date:  2015-11-12       Impact factor: 3.161

2.  Inactivation of Aggregatibacter actinomycetemcomitans by two different modalities of photodynamic therapy using Toluidine blue O or Radachlorin as photosensitizers: an in vitro study.

Authors:  Neda Moslemi; Pardis Soleiman-Zadeh Azar; Abbas Bahador; Nina Rouzmeh; Nasim Chiniforush; Mojgan Paknejad; Reza Fekrazad
Journal:  Lasers Med Sci       Date:  2014-07-01       Impact factor: 3.161

3.  Photodynamic Inactivation of Porphyromonas gingivalis utilizing Radachlorin and Toluidine Blue O as Photosensitizers: An In Vitro Study.

Authors:  Neda Moslemi; Nina Rouzmeh; Fatemeh Shakerinia; Abbas Bahador; Pardis Soleimanzadeh Azar; Mohammad Javad Kharazifard; Mojgan Paknejad; Reza Fekrazad
Journal:  J Lasers Med Sci       Date:  2018-03-20

4.  Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.

Authors:  En Hyung Chang; Peter Giaquinto; Joanne Huang; Nataliya V Balashova; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2019-12-26       Impact factor: 3.563

Review 5.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

6.  A clinically hidden but severely destructive entity.

Authors:  Khushboo Rastogi; Santosh Kumar Verma; Rajarshi Bhushan
Journal:  BMJ Case Rep       Date:  2013-06-27

7.  An In Vitro Comparison of Antimicrobial Effects of Curcumin-Based Photodynamic Therapy and Chlorhexidine, on Aggregatibacter actinomycetemcomitans.

Authors:  Shamsoulmolouk Najafi; Mina Khayamzadeh; Mojgan Paknejad; Golfam Poursepanj; Mohammad Javad Kharazi Fard; Abbas Bahador
Journal:  J Lasers Med Sci       Date:  2016-01-07

8.  Catechin-mediated restructuring of a bacterial toxin inhibits activity.

Authors:  En Hyung Chang; Joanne Huang; Zixiang Lin; Angela C Brown
Journal:  Biochim Biophys Acta Gen Subj       Date:  2018-10-17       Impact factor: 3.770

9.  Receptor-Based Peptides for Inhibition of Leukotoxin Activity.

Authors:  Eric Krueger; Shannon Hayes; En Hyung Chang; Shailagne Yutuc; Angela C Brown
Journal:  ACS Infect Dis       Date:  2018-05-17       Impact factor: 5.084

10.  Antibiotics in the management of aggressive periodontitis.

Authors:  Abinaya Prakasam; S Sugumari Elavarasu; Ravi Kumar Natarajan
Journal:  J Pharm Bioallied Sci       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.